Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets. - Test2 - elhamkhani - TriplyDB

Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.

Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.

http://www.wikidata.org/entity/Q36745194

about

Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation.Recent progress on lipid lateral heterogeneity in plasma membranes: From rafts to submicrometric domains Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease.Pathogenic roles of microvesicles in diabetic retinopathy.Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.Human Induced Pluripotent Stem Cell-Derived Microvesicles Transmit RNAs and Proteins to Recipient Mature Heart Cells Modulating Cell Fate and Behavior.Glucose and angiotensin II-derived endothelial extracellular vesicles regulate endothelial dysfunction via ERK1/2 activation.Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.Circulating microparticles from diabetic rats impair endothelial function and regulate endothelial protein expression.Platelets microparticles as a link between micro- and macro-angiopathy in young patients with type 1 diabetes.ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy.Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications.β cell membrane remodelling and procoagulant events occur in inflammation-driven insulin impairment: a GLP-1 receptor dependent and independent control.Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases.Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction.Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36.Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes.The signature of circulating microparticles in heart failure patients with metabolic syndrome.Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use.

P2860

Q26764843-2AC84997-F9F2-4141-87E5-28553311BC83 Q26797260-253E60BD-363C-41A6-BFE2-612D2323C4F4 Q28071774-C5C00F5C-F76B-4FF7-B046-25F464DBF08A Q36324332-6730B592-7BC3-499D-B220-AE85B7853ABA Q36854004-543281F2-C227-4037-B6D0-1646BC2E20D1 Q37611255-6B939050-C41F-49B3-A777-B44AB2429A46 Q38656787-C9966FEC-C0A7-4CF1-9CBD-17FDDEC6D0DF Q38791503-446361FB-CBEF-427A-95EE-F258EC524107 Q39000837-BF212253-99C0-41D4-B000-6B182546091F Q39099983-E1F7A1A4-E712-4525-A3B4-8987BFC35A65 Q40061733-A0D22D17-D743-49D6-8E24-46CD24115C81 Q40667685-F66F6C9A-E5A8-4405-88C2-37A26621194C Q41166174-B38C8925-7212-40FF-AF33-EBF345E6ADAF Q41458803-C979207F-E672-4AAA-88C0-84F421291439 Q41974700-02272AB6-6A9B-4F31-88F5-8776375E748D Q42109004-6E270DB6-F6D4-44C3-AAD1-E0266A7277EB Q42176525-53AB7D03-6BC1-4394-825F-215455C102B1 Q47139699-4281CB29-708A-48A6-9292-49C4AA238AE5 Q49805134-34E8DA99-2ADD-429F-B40D-B6D11165C275 Q49807920-A7EA25AE-FD29-418F-AFD6-5C5E25C1E190 Q50072140-0DAA1E7E-6AE0-47E9-8FD1-E9CB66C6C27F Q52086673-4A8B6E85-089F-4BF5-A97B-32EB0A5741B2 Q54950937-964C56FD-AE9A-4F80-86DE-11ACB52F34A8

P2860

Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.

http://www.wikidata.org/entity/Q36745194

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Microvesicles and diabetic com ...... rkers and therapeutic targets.

@ast

Microvesicles and diabetic com ...... rkers and therapeutic targets.

@en

type

label

Microvesicles and diabetic com ...... rkers and therapeutic targets.

@ast

Microvesicles and diabetic com ...... rkers and therapeutic targets.

@en

prefLabel

Microvesicles and diabetic com ...... rkers and therapeutic targets.

@ast

Microvesicles and diabetic com ...... rkers and therapeutic targets.

@en

P1433

Q36745194-46755384-533A-4676-AEE0-AB429E5EBCB4

P1476

Q36745194-6198762D-79E5-482E-8A50-4C4D72C56DDF

P2093

Q36745194-49DE559E-6DAB-4380-9994-F78934917F64

Q36745194-8A6331AB-D369-4C84-ADDC-02033DF64341

Q36745194-F912A29C-98D0-47F3-94F0-91CC844C7D59

P2860

Q36745194-0093F509-51D4-4F49-8EB4-F6553FDFEB45

Q36745194-0349FD7C-03DB-4915-895E-88B362865924

Q36745194-04919372-C518-4068-A99F-C4DCA7270CB2

Q36745194-083B29B3-43AC-40E8-9809-1D9E3FEB0902

Q36745194-08F1C884-F73F-4B3B-B727-C5B86069564D

Q36745194-094140DE-3063-4110-9D68-EE160F0BF84B

Q36745194-098085B3-244B-4926-B2BC-F7A946C04226

Q36745194-09A1A794-7EBE-435E-9BD1-977D4CA13A5E

Q36745194-0B766174-AC86-4410-AFEB-FB7CB7AA924E

Q36745194-0C609E4A-2F63-4266-80E5-88427878CA65

P2888

Q36745194-D5ABDF85-EEBF-4F2A-A455-E93228300673

P304

Q36745194-B16A7654-50C3-4C38-9EE6-722BC02FA0C4

P31

Q36745194-EA819B09-92A0-40F9-B257-84D97B8E3A2D

P356

Q36745194-92951B09-B772-4E76-84E0-26EDFFA415AC

P433

Q36745194-FA45C0AD-1789-4B34-A68F-1E130D7D6C70

P478

Q36745194-4F9D318D-2E68-4546-A61A-5744A2325DAB

P577

Q36745194-6D1C31E9-2756-4515-A88D-792370A91E62

P5875

Q36745194-4B8ED7DB-DE51-49BE-9886-4DBF60E61EEC

P698

Q36745194-C35C776E-9BBD-46D9-A5F1-C103D83B840C

P921

Q36745194-815054D7-B5E8-45B6-90A8-A33E9A6EC2FC

P932

Q36745194-BED38520-4097-42B7-A939-BBCB50B2376C

P356

P1433

Acta Pharmacologica Sinica

P1476

Microvesicles and diabetic com ...... rkers and therapeutic targets.

@en

P2093

Li-ming Chen

http://www.w3.org/2001/XMLSchema#string

Ming-lin Liu

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages

AngiomiRs--key regulators of angiogenesis

Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats

Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification.

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.

Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation

Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

P2888

P304

433-443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2013.188

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260645587

http://www.w3.org/2001/XMLSchema#string

P698

24608676

http://www.w3.org/2001/XMLSchema#string

P921

P932

4813723

http://www.w3.org/2001/XMLSchema#string